research use only
Cat.No.S7128
| Related Targets | HDAC JAK BET Histone Methyltransferase PKC PARP HIF PRMT AMPK Sirtuin |
|---|---|
| Other EZH2 Inhibitors | PF-06821497 GSK126 Tulmimetostat (CPI-0209) GSK343 CPI-169 MS1943 SHR2554 EZH2/HSP90-IN-29 EBI-2511 Igermetostat |
|
In vitro |
DMSO
: 100 mg/mL
(174.59 mM)
Water : Insoluble Ethanol : Insoluble The solubility data above are all experimental results (not literature values). |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
Read more about EPZ-6438 (Tazemetostat) solubility in DMSO or water
Read more about EPZ-6438 (Tazemetostat) working concentrations for cell culture treatment
| Information | EPZ-6438 (Tazemetostat) is a potent and highly selective EZH2 inhibitor. It works by binding to the EZH2 enzyme, blocking H3K27 methylation and PRC2-mediated epigenetic silencing. This reactivates tumor suppressors, showing high therapeutic value in lymphomas and sarcomas. |
|---|---|
|
Read more about EPZ-6438 (Tazemetostat) IC50 for cell-based and cell-free assays |
|
| Primary Applications and Mechanism of Action | |
| Molecular Weight | 572.74 | Formula | C34H44N4O4 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 1403254-99-8 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | E7438 | Smiles | CCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3=C(C=C(NC3=O)C)C)C4=CC=C(C=C4)CN5CCOCC5 | ||
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.
Question 1:
Could you please help test the formulation of it for in vivo studies?
Answer:
We've tried some vehicles for it, and found this compound can be dissolved in 2% DMSO+30% PEG 300+5% Tween+ddH2O at 5 mg/ml as a clear solution. Dissolved in 5% DMSO+0.5% CMC Na at 15 mg/ml, it is a suspension for oral gavage.